Nano Science and Technology Institute - NSTI  
Nano Science and Technology Institute   Home | Subscribe | Site Map  
  ABOUT | COURSES | EVENTS | PUBLICATIONS | LEADERSHIP | OUTREACH | NEWS | PRESS | JOBS | Nanotechnology Solutions
px
px fade_top
Publications
Nanotech 2008 CDROM
Nanotech 2007 CDROM
Nanotech 2006 CDROM
Nanotech 2005 CDROM
Nanotech 2004 CDROM
3 CDROM Special Offer
Nanotech 2008 Vol. 1
Nanotech 2008 Vol. 2
Nanotech 2008 Vol. 3
Nanotech 2007 Vol. 1
Nanotech 2007 Vol. 2
Nanotech 2007 Vol. 3
Nanotech 2007 Vol. 4
Nanotech 2006 Vol. 1
Nanotech 2006 Vol. 2
Nanotech 2006 Vol. 3
Nanotech 2005 Vol. 1
Nanotech 2005 Vol. 2
Nanotech 2005 Vol. 3
WCM 2005
Nanotech 2004 Vol. 1
Nanotech 2004 Vol. 2
Nanotech 2004 Vol. 3
Nanotech 2003 Vol. 1
Nanotech 2003 Vol. 2
Nanotech 2003 Vol. 3
Nanotech 2002 Vol. 1
Nanotech 2002 Vol. 2
Nanotech 2001 Vol. 1
Nanotech 2001 Vol. 2
MSM 2000
MSM 99
MSM 98
Index of Authors
Index of Keywords
Index of Affiliations
Library Request Form
Shopping Cart
Order Form
 
Publications Publications
Nanotech 2007 Vol. 2
p
 
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 2
Nanotech 2007 Vol. 2
Technical Proceedings of the 2007 NSTI Nanotechnology Conference and Trade Show, Volume 2
 
Chapter 10: Nano Medicine
 

Optimizing Quantum Dot-Conjugated Immunoliposomes for Cancer Diagnostics and Targeted Therapeutics

Authors:K.C. Weng, C.O. Noble, B. Papahadjopoulos-Sternberg, F.F. Chen and J.W. Park
Affilation:UCSF Comprehensive Cancer Center, US
Pages:776 - 779
Keywords:quantum dots, immunoliposomes, nanomedicine, anti-HER2, targeted drug delivery systems
Abstract:A multifunctional nanoparticle that combines the optical properties of luminescent quantum dots (QDs) and therapeutic modality of immunoliposomes (ILs) has been developed. Carboxylate-derivatized QDs cross-linked with amino- poly(ethylene glycol)-functionalized liposomes were modified with anti-human epidermal growth factor receptor 2 (anti- HER2) scFv, resulting in quantum dot-conjugated immunoliposomes (QD-ILs). QD-ILs exhibited highly efficient and specific internalization by HER2-overexpressing tumor cells and facilitated long-term tracking of the drug delivery systems in vitro. However, reduced uptake and increased cell surface binding were observed for some aggregated, bulkier QD-ILs. To use QD-ILs for in vivo applications, a thorough understanding of the physical properties of the nanocomplex is necessary. A systematic investigation on how the synthesis parameters, particularly the ratios of various reagents and building components, affect the geometry, degree of crosslinking, and the interactions of resulting nanostructures with cells is reported in this study. Flow cytometry is used to quantitate the amount of cellular uptake while spatial distributions of QD-ILs within the cellular matrix are determined by confocal microscopy. Freeze-fracture electron microscopy and dynamic light scattering are used to characterize the morphology and size of nanostructures. The study also provides guidelines for the design of nanomedicine from the perspective of cellular interactions.
ISBN:1-4200-6183-6
Pages:838
Hardcopy:$199.99
 
Order:Mail/Fax Form
Special:3 CD Set — 15% off with Free Shipping
Up
Upcoming Events
Nanotech 2009
Cleantech 2009
BioNano 2009
TechConnect Summit
nanoPRwire™
nanoPRwire
News Headlines
nano World news
 
 
 
 
px
© Nano Science and Technology Institute     About NSTI | Terms of Use | Privacy Policy | Contact